The U.S. District Court for the District of New Jersey didn’t err in construing the term “wherein” in a way that narrowed the patent and favored Allergan, the U.S. Court of Appeals for the Federal Circuit said.
Allergan sued Sandoz in the New Jersey District Court, arguing Sandoz’s application to create a generic version of Combigan infringed three of its patents. The district court granted Allergan a preliminary injunction.
On appeal, Sandoz challenged the district court’s construction of...
For more stories, analysis and expertiseOR Request Trial
(Updates throughout to add comment.)